In September, 2003, a team from St. Vincent’s Hospital (Melbourne, Australia) published a piece in Journal of Clinical Neuroscience titled “The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months.” That article, by F.J. Vajda et
Dangerous Drugs & Medical Devices
News & Commentary on Prescription Drug & Medical Device Lawsuits
The blog published by Justinian Lane focuses on legal issues related to dangerous drugs and medical devices, with particular attention to asbestos and mesothelioma claims. It covers topics such as asbestos litigation, trust funds, sources of asbestos exposure, and related diseases. The blog also addresses legal challenges involving medical devices like inferior vena cava (IVC) filters, including their usage guidelines, complications, and FDA regulatory actions. Additionally, it discusses litigation against chemical companies for harmful products, FDA warnings to medical device manufacturers, and other product liability matters involving pharmaceuticals and medical devices.
Latest from Dangerous Drugs & Medical Devices - Page 7
1999 – Researchers find Depacon, Depakene, and Depakote linked to major congenital abnormalities
By Jared Fink
Published in a 1999 edition of Annals of Neurology, an article by E.B. Samrén et al. titled “Antiepileptic drug regimens and major congenital abnormalities in the offspring.” provides important insight into the risks of prenatal exposure to antiepileptic…
Prenatal exposure to Depacon, Depakene, Depakote linked to lower intelligence in children
By Jared Fink
Over the past ten years or so, dozens of studies have been published linking prenatal exposure to the antiepileptic drugs Depacon, Depakene, and Depakote (Abbott Laboratories, Inc.) with birth defects. Here, I will summarize one such study,…
1997 – Team finds Depacon / Depakene / Depakote to lift malformation risk up to 700%
By Jared Fink
Back in 1997, a team of Dutch medical researchers led by E.B. Samrén published an article titled “Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with…
Birth defects risk 2-3 times higher with Depacon exposure
By Jared Fink
From a team of Swedish researchers, an article appearing in the November, 2009 edition of Neurologic Clinics titled “Teratogenic effects of antiepileptic medications.” provides important insight into the connection between prenatal exposure to epilepsy drugs Depacon, Depakene, and…
2011 – Depakote only drug to lift birth defect risk in polytherapy
By Jared Fink
A study titled “Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.” by L.B. Holmes and a team from MassGeneral Hospital for Children (Boston, MA) published in the October, 2011 edition of Archives of Neurology further…
New England Journal of Medicine: Depacon Causes Defects, Decreased Cognitive Function
By Jared Fink
Titled “Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.”, an article by K.J. Meador and a team from Emory University published in the April, 2009 edition of New England Journal of Medicine provides…
Depacon, Depakote, and Depakene carry risk for birth defects at 6.7%
By Jared Fink
In February of this year, E. Campbell and a team from Royal Victoria Hospital (Belfast, UK) published a piece in Journal of Neurology, Neurosurgery, and Psychiatry titled “Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the…
Reduced cognitive ability linked to prenatal Depacon / Depakene / Depakote exposure
By Jared Fink
In March, 2013, a medical research team led by K.J. Meador published an article in Lancet Neurology titled “Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.”. This team from…
Depakote linked to birth defects, poor neonatal development
By Jared Fink
In recent years, a number of independent medical research teams have determined that prenatal exposure to antiepileptic drugs branded Depacon, Depakene, and Depakote is linked to increased risk for birth defects. Here, I will discuss research from one such team…